SUNNYVALE, CA--(Marketwired - November 17, 2014) - Viveve Medical, Inc. ("Viveve") (PINKSHEETS: VIVMF), a company focused on women's health, today announced that Patricia Scheller, Chief Executive Officer, will present at the Canaccord Genuity, 2014 Medical Technology & Diagnostics Forum on Thursday, November 20th at 8:20am EST at the Westin Grand Central in New York, NY.
Therapeutics, Inc. (NASDAQ:OSIR), the leading cellular and
regenerative medicine company focused on developing and marketing
products to treat conditions in wound care, orthopaedics and sports
medicine, announced today that Lode Debrabandere, Ph.D., President and
Chief Executive Officer, is scheduled to present at the Canaccord
Genuity Medical Technology and Diagnostics Forum on Thursday, November
20, 2014 at 9:00 a.m. ET in New York City.
New research from Siemens’ Financial Services unit (SFS) shows that
finance is playing an increasingly important role in enabling medical
equipment acquisition for healthcare organizations around the globe.
GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of
automated, multiplex molecular diagnostic testing systems, will present
at the Canaccord Genuity Medical Technology and Diagnostics Forum to be
held at the Westin Grand Central Hotel in New York, NY on Thursday,
November 20, 2014.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.